JP2023522402A5 - - Google Patents
Info
- Publication number
- JP2023522402A5 JP2023522402A5 JP2022564255A JP2022564255A JP2023522402A5 JP 2023522402 A5 JP2023522402 A5 JP 2023522402A5 JP 2022564255 A JP2022564255 A JP 2022564255A JP 2022564255 A JP2022564255 A JP 2022564255A JP 2023522402 A5 JP2023522402 A5 JP 2023522402A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- mir
- item
- vitamin
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063014633P | 2020-04-23 | 2020-04-23 | |
| US63/014,633 | 2020-04-23 | ||
| US202063047206P | 2020-07-01 | 2020-07-01 | |
| US63/047,206 | 2020-07-01 | ||
| US202063064305P | 2020-08-11 | 2020-08-11 | |
| US63/064,305 | 2020-08-11 | ||
| PCT/IB2021/053353 WO2021214720A1 (en) | 2020-04-23 | 2021-04-23 | Diagnostic methods using mir-485-3p expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023522402A JP2023522402A (ja) | 2023-05-30 |
| JP2023522402A5 true JP2023522402A5 (https=) | 2024-05-07 |
Family
ID=78270846
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022564255A Pending JP2023522402A (ja) | 2020-04-23 | 2021-04-23 | Ｍｉｒ－４８５－３ｐの発現を用いた診断方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230167502A1 (https=) |
| EP (1) | EP4139488A4 (https=) |
| JP (1) | JP2023522402A (https=) |
| KR (1) | KR20230014705A (https=) |
| CN (1) | CN115917008A (https=) |
| AU (1) | AU2021260191A1 (https=) |
| CA (1) | CA3175419A1 (https=) |
| WO (1) | WO2021214720A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090156459A1 (en) * | 2007-11-16 | 2009-06-18 | Pharmain Corporation | Cationic-Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
| RU2626540C2 (ru) * | 2011-04-18 | 2017-07-28 | Диамир, Ллс | Способы обнаружения патологических изменений в органе или системе органов |
| US9951330B2 (en) * | 2013-07-11 | 2018-04-24 | The Trustees Of Columbia University In The City Of New York | Micrornas that silence tau expression |
| CN105917005B (zh) * | 2013-11-18 | 2020-09-11 | 迪阿米尔有限责任公司 | 使用来自体液的miRNA检测和监控帕金森病(PD)的方法 |
| WO2018139759A1 (ko) * | 2017-01-26 | 2018-08-02 | 주식회사 바이오오케스트라 | 마이크로 rna를 이용한 알츠하이머병 진단방법 |
| WO2018139819A1 (ko) * | 2017-01-26 | 2018-08-02 | 주식회사 바이오오케스트라 | 마이크로 rna를 이용한 뇌 질환 예방 또는 치료 용도 |
| KR102105016B1 (ko) * | 2019-12-12 | 2020-04-28 | 주식회사 바이오오케스트라 | miR-485-3p를 이용한 알츠하이머병 진단 방법 |
-
2021
- 2021-04-23 CA CA3175419A patent/CA3175419A1/en active Pending
- 2021-04-23 KR KR1020227041165A patent/KR20230014705A/ko active Pending
- 2021-04-23 US US17/997,000 patent/US20230167502A1/en not_active Abandoned
- 2021-04-23 WO PCT/IB2021/053353 patent/WO2021214720A1/en not_active Ceased
- 2021-04-23 CN CN202180043984.XA patent/CN115917008A/zh active Pending
- 2021-04-23 JP JP2022564255A patent/JP2023522402A/ja active Pending
- 2021-04-23 AU AU2021260191A patent/AU2021260191A1/en not_active Abandoned
- 2021-04-23 EP EP21791933.1A patent/EP4139488A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240139340A1 (en) | Method to enhance the efficiency of systemic aav gene delivery to the central nervous system | |
| US12291719B2 (en) | Heterologous targeting peptide grafted AAVs | |
| WO2019207132A1 (en) | Modified aav capsid polypeptides for treatment of muscular diseases | |
| JP5826174B2 (ja) | 核酸送達用組成物及び担体組成物、それを用いた医薬組成物、並びに核酸送達方法 | |
| Koppu et al. | Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA | |
| Koji et al. | Bundling of mRNA strands inside polyion complexes improves mRNA delivery efficiency in vitro and in vivo | |
| Kim et al. | Multifunctional polyion complex micelle featuring enhanced stability, targetability, and endosome escapability for systemic siRNA delivery to subcutaneous model of lung cancer | |
| CN116425973B (zh) | 一种pH响应型的肝靶向的药物递送载体及其制备方法和应用 | |
| EP4284927A2 (en) | Epigenetic gene regulation to treat neurological diseases and pain | |
| Pan et al. | In vitro gene transfection in human glioma cells using a novel and less cytotoxic artificial lipoprotein delivery system | |
| JP2023522402A5 (https=) | ||
| JP2023513190A5 (https=) | ||
| JP2023532536A5 (https=) | ||
| US20240358846A1 (en) | Nanoparticles and Peptides for the Delivery of Cargos to Muscle Cells | |
| JP2023513188A5 (https=) | ||
| Ooya et al. | Effects of polyrotaxane structure on polyion complexation with DNA | |
| EP4124348A1 (en) | Nanoparticles for cell delivery | |
| Wang et al. | Engineering peptide‐oligonucleotide nano‐conjugates via click reaction as self‐delivery system for gene therapy of inflammatory arthritis | |
| US12582669B2 (en) | Composition controlling pharmacokinetics in the body | |
| JP2023513189A5 (https=) | ||
| CN113660938A (zh) | 核酸递送复合物 | |
| AU2016348759A1 (en) | AAV/UPR-plus virus, UPR-plus fusion protein, genetic treatment method and use thereof in the treatment of neurodegenerative diseases, such as Parkinson's disease and Huntington's disease, inter alia | |
| Garcia et al. | Integrated AAV optimization enables efficient gene delivery to kidney in murine and human tissue | |
| Wang et al. | Tris [2-(Acryloyloxy) Ethyl] Isocyanurate Cross-Linked Polyethylenimine Enhanced Exon-Skipping of Antisense 2'-Omethyl Phosphorothioate Oligonucleotide in vitro and in vivo | |
| EP4124345A1 (en) | Nanoparticles for muscle delivery |